
Aptorum Group Limited APM
€ 0.74
5.24%
Geschäftsbericht 2024
hinzugefügt 07.02.2026
Aptorum Group Limited Betriebszyklus 2011-2026 | APM
Betriebszyklus Jährlich Aptorum Group Limited
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 4.89 | 20.6 | 14.8 | 1.35 | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 20.6 | 1.35 | 10.4 |
Betriebszyklus anderer Aktien in der Pharmaeinzelhändler
| Name | Betriebszyklus | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Akebia Therapeutics
AKBA
|
166 | $ 1.48 | -1.67 % | $ 277 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | ||
|
Amarin Corporation plc
AMRN
|
157 | $ 14.7 | -0.34 % | $ 5.99 B | ||
|
ANI Pharmaceuticals
ANIP
|
295 | $ 79.9 | -0.55 % | $ 1.54 B | ||
|
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M | ||
|
I-Mab
IMAB
|
271 | - | - | $ 866 M | ||
|
Alexion Pharmaceuticals, Inc.
ALXN
|
12.8 | - | - | $ 40.3 B | ||
|
Adagene
ADAG
|
53.8 | $ 2.66 | -0.37 % | $ 150 M | ||
|
Midatech Pharma plc
MTP
|
245 | - | -18.52 % | $ 27.3 M | ||
|
EyeGate Pharmaceuticals, Inc.
EYEG
|
32 | - | -1.52 % | $ 24.7 M | ||
|
Acorda Therapeutics
ACOR
|
394 | - | -24.86 % | $ 820 K | ||
|
Compugen Ltd.
CGEN
|
60.8 | $ 1.75 | 2.05 % | $ 157 M | ||
|
Albireo Pharma
ALBO
|
40.8 | - | -0.23 % | $ 916 M | ||
|
Институт стволовых клеток человека
ISKJ
|
104 | - | - | - | ||
|
Aptinyx
APTX
|
46.9 | - | -39.0 % | $ 4.57 M | ||
|
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | ||
|
Corcept Therapeutics Incorporated
CORT
|
364 | $ 41.12 | -0.46 % | $ 4.24 B | ||
|
Aridis Pharmaceuticals
ARDS
|
59 | - | 17.91 % | $ 11.1 M | ||
|
Aeterna Zentaris
AEZS
|
115 | - | 5.93 % | $ 314 M | ||
|
Catalyst Pharmaceuticals
CPRX
|
137 | $ 24.29 | -0.67 % | $ 2.88 B | ||
|
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | ||
|
CRISPR Therapeutics AG
CRSP
|
1.1 K | $ 49.94 | 0.48 % | $ 4.21 B | ||
|
Champions Oncology
CSBR
|
66.5 | $ 6.54 | -0.15 % | $ 89.3 M | ||
|
Amneal Pharmaceuticals
AMRX
|
123 | $ 14.48 | -0.28 % | $ 4.47 B |